Friday, May 19, 2023 3:30:30 PM
No claim as to the relevance or monetary value of the information is made herein. Any opinion stated is my own, and should not be used for investment purposes. No preference of any particular derivative is implied, in spite of wording thereof
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation • GNPX • Sep 20, 2023 8:45 AM
Caduceus Provides Update on Its Plans for The Second Half of The Fiscal Year • CSOC • Sep 20, 2023 8:26 AM
RESILIENT ENERGY INC. (RENI) PURSUING ACQUISITION TARGETS • RENI • Sep 19, 2023 10:30 AM
Aether Global Innovations Corp. Signs Strategic Partnership MOU with STA, a cutting-edge, innovative and bespoke technology solutions provider • AETHF • Sep 19, 2023 9:11 AM
From Instagram to High Times: Unpacking the Power of Vast User Networks • META • Sep 19, 2023 8:45 AM
Volcon, Inc. Announces Improved Debt Position and Strategic Cost Reduction • VLCN • Sep 18, 2023 9:34 AM